StockData
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Medline Inc.

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)

Close on Oct 19, 2026

Market cap
$30.29B
P/E (TTM)
–
Dividend yield
–

About Medline

Surgical & Medical Instruments & Apparatus, SIC 3841

Medline Inc. manufactures and distributes medical-surgical supplies and provides healthcare supply chain management services. The company conducts business through two reportable segments: Medline Brand and Supply Chain Solutions. Through its Medline Brand segment, it provides proprietary items spanning patient front-line care, surgical and perioperative environments, and laboratory diagnostics, including wound care supplies, examination gloves, surgical procedure kits, and diagnostic instruments. Through its Supply Chain Solutions segment, Medline distributes third-party medical products alongside logistics optimization, third-party warehousing, consulting, and inventory management services. Its customers encompass all healthcare care settings, including hospitals, ambulatory surgery centers, physician clinics, and post-acute facilities.

The company employs over 45,000 workers worldwide, with more than 26,000 located in the United States and substantial teams in countries such as Mexico, the Dominican Republic, India, Canada, Slovakia, France, China, Japan, Germany, and Australia. Medline operates 30 manufacturing plants, 24 of which are in North America, and maintains 70 global distribution centers, warehouses, and transit hubs, with 45 across the United States supported by a private transport fleet exceeding 2,100 delivery trucks. The provided text does not mention the location of its headquarters.

Summary of the business section of Medline's latest annual report, written by StockData.

Company profile

Company

Legal name
Medline Inc.
Founded
1966
Headquarters
Northfield, IL
Address
3 Lakes Drive 60093
Phone
(847) 949-3000
Employees
45,000, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Chicago, Illinois

Stock & identifiers

Ticker
MDLN
Exchange
Nasdaq
IPO date
Dec 18, 2025
Shares outstanding
1.31B, Aug 3, 2026
Public float
$13.00B, Dec 17, 2025
Filer category
Non-accelerated filer
SEC CIK
2046386
CUSIP
58507V107
ISIN
US58507V1070
LEI
984500FAN6J1P8566D43
EIN
33-1845288

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
James M. BoyleChief Executive Officer, Director568,558
Stephen L. MillerChief Operating Officer23,899
William J. AbramsSee Remarks542,881
Amanda H. LaabsChief Product Officer274,969
Douglas P. GolwasChief Commercial Officer427,797
Alexander M. LibermanChief Legal Officer472,131
Michael B. DrazinChief Financial Officer509,927
Christopher P. ShryockChief Human Resources Officer11,031
Jessi L. CorcoranPrincipal Accounting Officer5,000
James M. PigottPresident1,206,467
Thomas W. SweetDirector17,800
Todd M. BluedornDirector15,732
Richard A. GalantiDirector16,392
Patrick J. HealyDirector1,599,493
Robert R. SchmidtDirector–
Stephen H. WiseDirector–
Charles N. MillsDirector2,643,315
Andrew J. MillsDirector2,616,861
Anushka M. SunderDirector–
Jacob BestDirector–
Joseph BarattaDirector–

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr.Boyle
$3.86M$61.84M$4.62M$102$101

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Corporate history

Events identified from SEC filings